April 14, 2025

ARUP is the first reference laboratory to offer a molecular measles assay that both detects the measles virus and distinguishes between infection-causing and vaccine strains of the virus.

January 27, 2025

A new ARUP white paper highlights the potential indirect costs of outsourcing laboratories and suggests ways for clinical laboratories to demonstrate their value to the health system.

January 8, 2025

ARUP Healthcare Advisory Services can help labs prepare for the quality management system requirements in the FDA’s final rule on laboratory-developed tests, despite the rule’s uncertain future.

Magnify logo

November 19, 2024

This edition features interviews with company leaders describing ARUP’s approaches to comply with the FDA’s rule and a video about how ARUP helped a family on a rare disease diagnostic journey.

November 6, 2024

Laboratory tests, including those for fluid biomarkers, may be used to diagnose Alzheimer's disease. ARUP Consult details using such tests to help clinicians order the right test at the right time.

September 13, 2024

ARUP has been awarded a CDC contract for avian influenza A (H5N1) test development, which recognizes our expertise and experience with assay development and our desire to serve public health needs.

July 29, 2024

The lone star tick, which can transmit infectious diseases and trigger a serious red meat allergy, is spreading into new areas. ARUP Consult offers guidance to help diagnose tickborne illnesses.

May 30, 2024

ARUP’s declaration amplifies the lawsuit’s claims that the FDA does not have legal authority over laboratory testing services and that regulating these services is unreasonable.